Samsung Biologics Names John Rim as President and CEO

PR Newswire
December 16, 2020 — 20:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: europe Expansion manufacturing pharmaceutical Samsung South Korea

Related News:

Bedrock Launches uniBTC and brBTC on Aptos, Expanding the Frontiers of BTCFi

September 4, 2025 — 23:22

ECOVACS 2024 Sustainability Report Highlights Its Commitment to Sustainability and Data Security

August 28, 2025 — 21:22

Lambda Builds AI Factories with Supermicro NVIDIA Blackwell GPU Server Clusters to Deliver Production-ready Next-Gen AI Infrastructure at Scale

August 25, 2025 — 21:05

EcoFlow Unveils New Power Bank Lineups, Redefining How We Charge for Work, Travel and Life

August 25, 2025 — 21:00

Everest Medicines Announces Participation in September Investor Conferences

August 25, 2025 — 20:57

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth

August 21, 2025 — 08:23

Ping An Good Doctor (1833.HK) Reports Strong Interim Results: Revenue and Profit Accelerate as AI Fuels New Growth Momentum

August 19, 2025 — 23:11

STRADVISION Reports Strong First Half of 2025, Expands SVNet Deployment

August 19, 2025 — 23:00

Appier’s historical high revenue, gross profit and operating profit signal continued profitable growth

August 15, 2025 — 00:10

Franchising and Licensing Asia (FLAsia) 2024